Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment- Pharmacoeconomic Analysis of a Prospective Randomized Trial
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1616
https://www.valueinhealthjournal.com/article/S1098-3015(16)01684-3/fulltext
Title :
Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment- Pharmacoeconomic Analysis of a Prospective Randomized Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01684-3&doi=10.1016/j.jval.2016.03.1616
First page :
A154
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
335